Factors Associated with Adoption of Immune Checkpoint Inhibitor Treatment for Advanced Melanoma: A SEER-Medicare Cohort Study-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Factors Associated with Adoption of Immune Checkpoint Inhibitor Treatment for Advanced Melanoma: A SEER-Medicare Cohort Study

Published:2024-07 Issue:4 Volume:4 Page:100289
ISSN:2667-0267
Container-title:JID Innovations
language:en
Short-container-title:JID Innovations

Author:

Mohr Cassandra^ORCID,Liao Kaiping^ORCID,Hinkston Candice L.^ORCID,Wehner Mackenzie R.^ORCID,Li Meng^ORCID

Publisher

Elsevier BV

Reference11 articles.

1. Trends in incidence and predictions of cutaneous melanoma across Europe up to 2015;Arnold;J Eur Acad Dermatol Venereol,2014

2. Undertreatment strongly decreases prognosis of breast cancer in elderly women;Bouchardy;J Clin Oncol,2003

3. Sex as a predictor of response to cancer immunotherapy;Carrera;Lancet Oncol,2018

4. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation;Charlson;J Chronic Dis,1987

5. Cutaneous melanoma, Version 2.2019, NCCN Clinical Practice Guidelines in Oncology;Coit;J Natl Compr Canc Netw,2019

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP